Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: PTC Therapeutics Inc., 3 years.
PTC Therapeutics Inc.
Director
NexGel Inc
Director
Soligenix Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
PTC Therapeutics Inc. June 2, 202696.1%
-
Soligenix Inc. June 20, 202590.3%
-
NexGel Inc June 17, 202594.1%
-
NexGel Inc June 17, 202496.5%
-
Soligenix Inc. May 30, 202484.8%
-
Soligenix Inc. December 15, 202361.4%
-
NexGel Inc June 6, 202396.4%
-
PTC Therapeutics Inc. June 6, 202387.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Jan 3, 2025 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Dec 2, 2024 | PTC Therapeutics Inc. | Option exercise | +12,000 | $51.00 | $612,000 |
| Dec 2, 2024 | PTC Therapeutics Inc. | Open-market sale | −8,813 | $51.44 | $453,341 |
| Dec 2, 2024 | PTC Therapeutics Inc. | Open-market sale | −3,187 | $52.42 | $167,063 |
| Dec 2, 2024 | PTC Therapeutics Inc. | Option exercise | +12,000 | $30.86 | $370,320 |
| Dec 2, 2024 | PTC Therapeutics Inc. | Open-market sale | −5,699 | $50.52 | $287,913 |
| Dec 2, 2024 | PTC Therapeutics Inc. | Open-market sale | −2,634 | $51.43 | $135,467 |
| Dec 2, 2024 | PTC Therapeutics Inc. | Open-market sale | −3,667 | $52.39 | $192,114 |
| Nov 20, 2024 | NexGel Inc | Open-market purchase | +3,636 | $2.75 | $9,999 |
| Aug 23, 2024 | NexGel Inc | Open-market purchase | +10,000 | $2.50 | $25,000 |
| May 22, 2024 | PTC Therapeutics Inc. | Option exercise | +20,000 | $26.42 | $528,400 |
| May 22, 2024 | PTC Therapeutics Inc. | Open-market sale | −20,000 | $38.24 | $764,800 |
| Feb 15, 2024 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| May 26, 2023 | NexGel Inc | Open-market purchase | +5,000 | $2.34 | $11,700 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.